[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK168291B1 - N-substituerede diphenylpiperidiner, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende forbindelserne samt anvendelse af forbindelserne samt anvendelse af forbindelserne til fremstilling af et lægemiddel til anvendelse til forebyggelse eller behandling af fedme - Google Patents

N-substituerede diphenylpiperidiner, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende forbindelserne samt anvendelse af forbindelserne samt anvendelse af forbindelserne til fremstilling af et lægemiddel til anvendelse til forebyggelse eller behandling af fedme Download PDF

Info

Publication number
DK168291B1
DK168291B1 DK475286A DK475286A DK168291B1 DK 168291 B1 DK168291 B1 DK 168291B1 DK 475286 A DK475286 A DK 475286A DK 475286 A DK475286 A DK 475286A DK 168291 B1 DK168291 B1 DK 168291B1
Authority
DK
Denmark
Prior art keywords
pyridine
diphenylethenyl
general formula
compounds
piperidinyl
Prior art date
Application number
DK475286A
Other languages
Danish (da)
English (en)
Other versions
DK475286A (da
DK475286D0 (da
Inventor
John Guilfoyle Mullin
Richard Wightman Kierstead
Joseph Triscari
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK475286D0 publication Critical patent/DK475286D0/da
Publication of DK475286A publication Critical patent/DK475286A/da
Application granted granted Critical
Publication of DK168291B1 publication Critical patent/DK168291B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK475286A 1985-10-07 1986-10-03 N-substituerede diphenylpiperidiner, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende forbindelserne samt anvendelse af forbindelserne samt anvendelse af forbindelserne til fremstilling af et lægemiddel til anvendelse til forebyggelse eller behandling af fedme DK168291B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/785,113 US4632925A (en) 1985-10-07 1985-10-07 N-substituted diphenylpiperidines and antiobesity use thereof
US78511385 1985-10-07

Publications (3)

Publication Number Publication Date
DK475286D0 DK475286D0 (da) 1986-10-03
DK475286A DK475286A (da) 1987-04-08
DK168291B1 true DK168291B1 (da) 1994-03-07

Family

ID=25134481

Family Applications (1)

Application Number Title Priority Date Filing Date
DK475286A DK168291B1 (da) 1985-10-07 1986-10-03 N-substituerede diphenylpiperidiner, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende forbindelserne samt anvendelse af forbindelserne samt anvendelse af forbindelserne til fremstilling af et lægemiddel til anvendelse til forebyggelse eller behandling af fedme

Country Status (23)

Country Link
US (1) US4632925A (fi)
EP (1) EP0221376B1 (fi)
JP (1) JPH0633254B2 (fi)
KR (1) KR870003984A (fi)
AR (1) AR241422A1 (fi)
AT (1) ATE53997T1 (fi)
AU (1) AU593844B2 (fi)
CA (1) CA1281326C (fi)
DE (1) DE3672134D1 (fi)
DK (1) DK168291B1 (fi)
ES (1) ES2005074A6 (fi)
FI (1) FI85020C (fi)
GR (1) GR862513B (fi)
HU (1) HU196200B (fi)
IE (1) IE59434B1 (fi)
IL (1) IL80232A0 (fi)
MC (1) MC1769A1 (fi)
NO (1) NO166127C (fi)
NZ (1) NZ217798A (fi)
PH (1) PH24167A (fi)
PT (1) PT83495B (fi)
SG (1) SG17593G (fi)
ZA (1) ZA867375B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78939A (en) * 1986-01-17 1990-04-29 Robins Co Inc A H Pharmaceutical compositions containing n-substituted arylalkyl-and arylalkylene-piperidines and tetrahydropyridines and certain such novel compounds
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
WO1992006971A1 (en) * 1990-10-10 1992-04-30 Schering Corporation Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
DK0635012T3 (da) * 1992-03-27 1996-08-19 Schering Corp Bis-aryl-carbinolderivater uden broer, præparater indeholdende disse og fremgangsmåder til anvendelse af disse
US6030987A (en) * 1996-05-17 2000-02-29 Fmc Corporation Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl]piperidines
US6017931A (en) * 1994-03-01 2000-01-25 Fmc Corporation Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines
US6184234B1 (en) * 1994-03-01 2001-02-06 Fmc Corporation Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl]piperidines
US5639763A (en) * 1994-03-01 1997-06-17 Fmc Corporation Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl)methyl]piperidines
AU5753696A (en) * 1995-05-19 1996-11-29 Fmc Corporation Insecticidal n-(substituted arylmethyl)-4-{bis(substituted p henyl or pyridyl)methyl}piperidines
US6407116B1 (en) 1997-09-16 2002-06-18 Takeda Chemical Industries, Inc. Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
US20100064413A1 (en) * 2008-03-14 2010-03-18 Simply Weights, LLC Exercise clothing and accessories
WO2009132978A1 (en) 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag 4-dimethylaminobutyric acid derivatives
EP2280935B1 (en) * 2008-04-29 2014-10-15 F. Hoffmann-La Roche AG 4-trimethylammonio-butyrates as cpt2 inhibitors
JP7269943B2 (ja) 2018-01-08 2023-05-09 エフ. ホフマン-ラ ロシュ アーゲー Magl阻害剤としてのオクタヒドロピリド[1,2-アルファ]ピラジン
CR20230115A (es) 2020-09-03 2023-04-11 Hoffmann La Roche Compuestos heterocíclicos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076717A (en) * 1971-12-15 1978-02-28 G. D. Searle & Co. Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3931197A (en) * 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US4650874A (en) * 1984-11-26 1987-03-17 G. D. Searle & Co. N-(aralkoxybenzyl)-4(benzhydryl) piperidines

Also Published As

Publication number Publication date
PT83495A (en) 1986-11-01
FI864051A0 (fi) 1986-10-07
NO863978L (no) 1987-04-08
HUT41768A (en) 1987-05-28
IE862636L (en) 1987-04-07
DK475286A (da) 1987-04-08
NO166127B (no) 1991-02-25
EP0221376A2 (de) 1987-05-13
FI85020B (fi) 1991-11-15
ATE53997T1 (de) 1990-07-15
IL80232A0 (en) 1987-01-30
DE3672134D1 (de) 1990-07-26
NO863978D0 (no) 1986-10-06
US4632925A (en) 1986-12-30
DK475286D0 (da) 1986-10-03
EP0221376A3 (en) 1987-09-02
NO166127C (no) 1991-06-05
PH24167A (en) 1990-03-22
HU196200B (en) 1988-10-28
PT83495B (pt) 1989-05-31
ES2005074A6 (es) 1989-03-01
SG17593G (en) 1993-05-21
JPS6287585A (ja) 1987-04-22
NZ217798A (en) 1989-10-27
CA1281326C (en) 1991-03-12
IE59434B1 (en) 1994-02-23
ZA867375B (en) 1987-05-27
FI85020C (fi) 1992-02-25
JPH0633254B2 (ja) 1994-05-02
FI864051A (fi) 1987-04-08
AR241422A1 (es) 1992-07-31
GR862513B (en) 1987-02-09
AU593844B2 (en) 1990-02-22
KR870003984A (ko) 1987-05-06
EP0221376B1 (de) 1990-06-20
MC1769A1 (fr) 1987-07-17
AU6350186A (en) 1987-04-09

Similar Documents

Publication Publication Date Title
DK168291B1 (da) N-substituerede diphenylpiperidiner, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende forbindelserne samt anvendelse af forbindelserne samt anvendelse af forbindelserne til fremstilling af et lægemiddel til anvendelse til forebyggelse eller behandling af fedme
US7265120B2 (en) Pyrazine derivatives and pharmaceutical use thereof
KR101171211B1 (ko) Mtp를 저해하는 5-원 헤테로사이클에 의해 치환된 아릴 피페리딘 또는 피페라진
EP1902046B1 (en) Piperidine derivatives useful as histamine h3 antagonists
US20060247439A1 (en) Mchir antagonists
US4680296A (en) Piperidine derivatives and pharmaceutical compositions containing them
WO1998004554A1 (fr) Antagonistes de recepteurs de chemokines
EP0679642A1 (en) Condensed heterocyclic compounds, their production and use
SK280812B6 (sk) 1,3-substituované cykloalkány a 1,3-substituované cykloalkény, spôsoby ich prípravy a farmaceutické prípravky na ich báze
PT2090570E (pt) Derivado de imidazole
NO141411B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
EP0237781A2 (en) Phenyl and heterocyclic tetrahydropyridyl and piperazinyl alkoxy-benzheterocyclic compounds as antipsychotic agents
JP3269574B2 (ja) メタノアントラセン化合物、これを含有する神経精神障害を治療するための調剤学的組成物、およびこの化合物を製造するための方法および中間体
DK151017B (da) Analogifremgangsmaade til fremstiiling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
Dallanoce et al. Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M
US7649002B2 (en) (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US5045550A (en) Substituted tetrahydropyridines as central nervous system agents
US5118691A (en) Substituted tetrahydropyridines as central nervous system agents
US5089497A (en) Substituted piperazines as central nervous system agents
EP1630159A1 (en) 5-HT7 receptor antagonists
US4448777A (en) 1-Phenylindazole-3-one compounds, process and intermediates for their preparation, and pharmaceutical compositions containing same
UA62966C2 (en) Quaternary ammonuim compounds as tachykinin antagonists
CN113166160B (zh) 作为毒蕈碱型m1受体正向别构调节剂的吡咯并哒嗪衍生物
US5187280A (en) Substituted tetrahydropyridines and their use as central nervous system agents
KR101586714B1 (ko) 피라졸 화합물